azathioprine has been researched along with clobetasol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chainani-Wu, N; Lozada-Nur, F; Mayer, P; Silverman, S; Watson, JJ | 1 |
| Bruckner-Tuderman, L; Hofmann, SC | 1 |
| Bennett, C; Khumalo, NP; Kirtschig, G; Middleton, P; Murrell, DF; Wojnarowska, F | 1 |
| Bernard, P; Charneux, J | 1 |
| Fechete, O; Grad, A; Seicean, A; Senilă, S; Ungureanu, L | 1 |
| Anchan, VN; Boyle, RJ; Chi, CC; Kirtschig, G; Murrell, DF; Singh, S; Taghipour, K | 1 |
3 review(s) available for azathioprine and clobetasol
| Article | Year |
|---|---|
Interventions for bullous pemphigoid.
Topics: Azathioprine; Clobetasol; Combined Modality Therapy; Drug Therapy, Combination; Drugs, Chinese Herbal; Glucocorticoids; Humans; Immunosuppressive Agents; Niacinamide; Pemphigoid, Bullous; Plasma Exchange; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Tetracycline | 2010 |
[Bullous pemphigoid: a review].
Topics: Aged; Azathioprine; Clobetasol; Combined Modality Therapy; Dapsone; Dose-Response Relationship, Drug; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Meta-Analysis as Topic; Multicenter Studies as Topic; Mycophenolic Acid; Niacinamide; Pemphigoid, Bullous; Plasma Exchange; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Tetracycline | 2011 |
Interventions for bullous pemphigoid.
Topics: Azathioprine; Clobetasol; Dapsone; Doxycycline; Humans; Methylprednisolone; Niacinamide; Pemphigoid, Bullous; Prednisone | 2023 |
4 other study(ies) available for azathioprine and clobetasol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Oral lichen planus: patient profile, disease progression and treatment responses.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Chronic Disease; Clobetasol; Disease Progression; Female; Fluocinonide; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lichen Planus, Oral; Male; Middle Aged; Mouth Neoplasms; Prednisone; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome | 2001 |
[Bullous pemphigoid: diagnostics and new therapeutic strategies].
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Biopsy; Blotting, Western; Child; Clobetasol; Cyclophosphamide; Dapsone; Dermatologic Agents; Diagnosis, Differential; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Direct; Fluorescent Antibody Technique, Indirect; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Mycophenolic Acid; Niacinamide; Pemphigoid, Bullous; Pregnancy; Skin; Vitamin B Complex | 2006 |
Infliximab-induced acne and acute localized exanthematous pustulosis: Case report.
Topics: Acne Vulgaris; Acute Generalized Exanthematous Pustulosis; Adult; Azathioprine; Azithromycin; Clobetasol; Crohn Disease; Drug Substitution; Female; Gastrointestinal Agents; Glucocorticoids; Humans; Infliximab; Remission Induction; Skin; Treatment Outcome | 2017 |